TABLE 15.5.
Adult Health Maintenance Checklist by Age Group
Age (years) |
|||
---|---|---|---|
Procedure | 20–39 | 40–64 | 65+ |
Checkup visit | Every 3 years | Every 2 years | Annually |
Cholesterol | With checkups | With checkups | With checkups |
Fecal occult blood | Age 40–49 if high risk | Annually | Annually |
Clinical breast examination | Every 1–3 years | Annuallya | Annuallya |
Mammography | Baseline age 35 | Age 40–49, every 1–2 years | Over 70, every 2 years |
Pelvic examination | Every 1–3 years | Every 1–3 years | Every 1–3 years |
Pap smear | From age 21-29 every 3 years; from 30-65 every 5 years with HPV DNA test | From age 30–65 every 5 years with HPV DNA test | If previously negative, may stop 3 years |
Colonoscopy | No | From age 40 for those with family history of colon cancer or polyps. After age 50, every 3–5 years | After age 50, every 3–5 years |
Prostate and PSA Immunizations | No | Annuallya | Annuallya |
Tetanus–diphtheria | Every 10 years | Every 10 years | Every 10 years |
Pneumococcal pneumonia | For high risk | For high risk | Every 6 years |
Influenza | For high risk | For high risk | Annually |
Skin cancer | Annuallya | Annuallya | Annuallya |
Bladder cancer | Annual routine urinalysis | Annual routine urinalysis | Annual routine urinalysis |
Lung cancer | Routine examinationb | Routine examinationb | Routine examinationb |
Testicular cancer | Routine examinationb | Routine examinationb | Routine examinationb |
Oral cancer | Routine examinationb | Routine examinationb | Routine examinationb |
Ovarian cancer | Routine examinationb | Routine examinationb | Routine examinationb |
Pancreatic cancer | Routine examinationb | Routine examinationb | Routine examinationb |
Routine vitamin supplements | Routineb | Routineb | Routineb |
Note:
PSA = prostate-specific antigen.
Agency for Healthcare Research and Quality. Rockville, MD: AHRQ. http://www.ahrq.gov [Accessed 13 September 2012].
Inconclusive
negative recommendation. The topics are under continuing review, and recommendations are in some cases left to the opinion of the provider as the current cumulative evidence is not affirmative, e.g., clinical breast examination annually or breast self-examination.
Sources: US Preventive Services Task Force Ratings: Strength of recommendations and quality of evidence. guide to clinical preventive services. 3rd ed. Periodic updates, 2000–2003. Available at: http://www.uspreventiveservicestaskforce.org/3rduspstf/ratings.htm [Accessed 13 September 2012].